SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-052250
Filing Date
2024-04-26
Accepted
2024-04-26 06:04:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm242716d2_defa14a.htm DEFA14A 8882
2 GRAPHIC tm242716d2_defa14aimg001.jpg GRAPHIC 167135
3 GRAPHIC tm242716d2_defa14aimg002.jpg GRAPHIC 113623
  Complete submission text file 0001104659-24-052250.txt   396873
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38129 | Film No.: 24878395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)